Saroglitazar magnesium
AssetAlso ZYH1, LIPAGLYN
Activates PPAR alpha and gamma to regulate lipid metabolism and improve insulin sensitivity.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Primary biliary cholangitis
Phase 3, Recruiting, NCT07216235, clinicaltrials.gov, 10 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials1
- Evidence for its targets3
- Competitors12
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.